Product information and disease descriptionPlace of product in therapyDisease description
Diagnosis
15 evidence topics · 12 sources
Histopathologic confirmation by core needle biopsy
“The histopathologic confirmation of DF is mandatory before initiating treatment.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A diagnosis of DF can be readily established on core biopsies using 14G or 16G needles, while neither incisional nor excisional biopsy is recommended as the initial diagnostic modality.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Expert soft tissue pathology review
CTNNB1 mutational analysis: guideline recommendation
CTNNB1 testing and screening for familial adenomatous polyposis in 226 patients
“226 patients were identified and 67% (n = 152) were female.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Colonoscopy was requested in 65 patients (28.8% of all cases) and was completed in forty-six (20.4%). Molecular testing of CTNNB1 testing was requested in 35 cases (15.5%). APC germline test was requested in 12 cases. Four patients in our cohort had an FAP-associated DF.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“CTNNB1 molecular testing should be performed in all cases of newly diagnosed DF. Negative CTNNB1 results, alongside clinical assessment, should prompt APC testing and/or colonoscopy.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Referral for colonoscopy by tumor location and age
“In conclusion, patients with desmoid-type fibromatoses are at risk of underlying FAP. Especially cases with desmoid localization intra-abdominal or in the abdominal wall, and all patients younger than 60 years, have a substantial increased risk and should be referred for colonoscopy.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
CTNNB1 sequencing in β-catenin-negative desmoid fibromatosis
“A single-center, large retrospective analysis of 780 patients with DF was performed.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“77.3% of DF cases exhibited nuclear β-catenin positivity.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Molecular analysis revealed that 74.1% of β-catenin negative cases harbored CTNNB1 mutations, primarily at codon 41 (p.T41A).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Notably, β-catenin IHC showed higher positivity in resected specimens (79.7%) compared to biopsies (62.0%), whereas CTNNB1 mutational detection was higher in biopsies (93.5%) than resections (76.8%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
CTNNB1 testing documented at a U.S. academic center
“Therefore, we aimed to characterize the patient journey in DTs from diagnosis to treatment at an academic center in the United States.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A much smaller proportion of patients had documentation of CTNNB1 testing ( n = 10, 6.7%), including seven with CTNNB1 mutation (4.7%) and three who were demonstrated to have the wild-type, nonmutated variant, which results in production of normal β-catenin (2%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Diagnostic methods, such as CTNNB1 testing, may also shorten the diagnostic journey.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Imaging: magnetic resonance imaging for diagnosis, local staging, and follow-up
“MRI is the mainstay of imaging in DF and can be used for diagnosis, local staging and follow-up” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The lack of radiation exposure makes targeted MRI ideal for follow-up.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Histopathological diagnosis is mandatory, and evaluation is guided with imaging studies ranging from ultrasound, computed tomography or magnetic resonance.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Ultrasound (US) serves as the initial evaluation especially for tumors in the extremities or abdominal wall.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Its appearance depends on the cellular composition where more fibrotic areas, with a greater amount of collagen, show a low signal intensity in T2 with moderate contrast enhancement.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Response assessment: RECIST and magnetic resonance imaging signal
Response assessment: T2-weighted signal intensity and tumor volume in the RINGSIDE phase 2 study
Response assessment: quantitative T2 mapping
“However, the primary imaging endpoints based on RECIST1.1 used in these studies are determined only by changes in maximum tumor diameter.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Analysis of T2 relaxation time maps of DF may offer a feasible quantitative biomarker for assessing the extent of response to treatment.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Misdiagnosis and time to diagnosis: participant-reported data
“A total of 162 participants (41%, 162/399) reported a prior misdiagnosis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The median age at the first sign or symptom of DT was 32 years, and the average time from the first sign or symptom to confirmed DT diagnosis was 4 years ( n = 292; median = 1 year).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The most reported differential diagnoses (70%, 113/162) were benign tumors or other conditions, including muscle injury, lipoma, colon polyps, postoperative scars, early-onset arthritis, hernia, and Baker’s cyst.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Among 126 participants who reported a prior misdiagnosis and history of surgery for DT, 46% (58/126) reported having received surgery before a definitive DT diagnosis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Misdiagnosis before confirmed diagnosis: U.S. academic center
“Therefore, we aimed to characterize the patient journey in DTs from diagnosis to treatment at an academic center in the United States.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 43 patients (29.1%) potentially had a misdiagnosis prior to a final confirmed diagnosis of DT based on tissue histology” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Most common misdiagnoses included other benign tumors ( n = 31, 20.3%), low-grade sarcomas ( n = 11, 7.2%), nodular fasciitis ( n = 4, 2.6%), and procedure-related scars ( n = 3, 2%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Histologic misdiagnosis in published series
“Based on pathologic similarities with other myofibroblastic diseases (e.g., sarcoma, gastrointestinal stromal tumor, nodular fasciitis, leiomyoma) and the low incidence of DT, 30–40% of DT cases are reported to be misdiagnosed following histologic analysis” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A French nationwide survey demonstrated that one-third of DT are misdiagnosed (the most challenging differential diagnoses are nodular fasciitis and low-grade fibromyxoid sarcoma)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote